
Progesterone CAS:57-83-0
Progesterone is a steroid hormone pivotal to reproductive health, embryonic development, and systemic physiological balance. Unlike estrogen, its "partner" hormone, progesterone is often underrecognized despite its multifaceted roles. Synthesized primarily in the ovaries (corpus luteum), placenta (during pregnancy), and adrenal glands, it operates as a biochemical modulator, influencing everything from menstrual cycles to neural function.
Introduction to Progesterone
Progesterone is a steroid hormone pivotal to reproductive health, embryonic development, and systemic physiological balance. Unlike estrogen, its "partner" hormone, progesterone is often underrecognized despite its multifaceted roles. Synthesized primarily in the ovaries (corpus luteum), placenta (during pregnancy), and adrenal glands, it operates as a biochemical modulator, influencing everything from menstrual cycles to neural function. This hormone's name derives from its pro-gestational role, essential for maintaining pregnancy. Structurally, it belongs to the C21 steroid family, characterized by a cyclopentanophenanthrene nucleus, making it lipid-soluble and capable of crossing cell membranes to interact with nuclear receptors.
Unique Insight: Recent studies suggest progesterone may act as a neurosteroid, influencing GABA receptors in the brain, which opens avenues for exploring its role in anxiety and seizure disorders-a frontier beyond traditional reproductive contexts.

Biochemical Features and Synthesis
Progesterone is synthesized from cholesterol via a cascade involving enzymes like CYP11A1 and 3β-HSD. Key features include:
●Hydrophobicity: Requires carrier proteins (e.g., corticosteroid-binding globulin) for blood transport.
●Receptor Binding: Binds to intracellular progesterone receptors (PR-A and PR-B), initiating genomic effects. Non-genomic actions occur via membrane-associated receptors (e.g., mPRs).
●Metabolism: Liver enzymes convert it to pregnanediol, excreted in urine.
Novel Angle: Emerging research highlights progesterone's interaction with immune cells, such as modulating T-regulatory cells to prevent fetal rejection-a mechanism critical in autoimmune pregnancy complications.
Applications in Medicine
3.1 Reproductive Health
●Luteal Phase Support: Used in IVF to thicken the endometrial lining, enhancing embryo implantation. Micronized vaginal progesterone (MVP) reduces systemic side effects compared to oral routes.
●Hormone Replacement Therapy (HRT): Mitigates menopausal symptoms when combined with estrogen, preventing endometrial hyperplasia.
●Endometriosis & PCOS: Suppresses ectopic tissue growth and stabilizes erratic ovulation cycles.
3.2 Non-Reproductive Uses
●Neuroprotection: Trials show progesterone reduces edema and improves outcomes in traumatic brain injury (TBI) by downregulating inflammatory cytokines.
●Cardiovascular Health: Enhances endothelial function via nitric oxide pathways, potentially reducing atherosclerosis risk in postmenopausal women.
●Bone Density: Stimulates osteoblast activity, offering a protective role against osteoporosis.
Understudied Application: Progesterone's anti-fibrotic properties are being explored in liver cirrhosis models, showing promise in reducing collagen deposition.
Benefits Beyond Conventional Use
●Mood Regulation: Correlates with allopregnanolone production, a neurosteroid that alleviates depression and anxiety (e.g., brexanolone for postpartum depression).
●Skin Health: Topical progesterone increases collagen synthesis and epidermal thickness, counteracting age-related dermal atrophy.
●Metabolic Impact: Modulates insulin sensitivity, with low levels linked to gestational diabetes risk.
Controversial Benefit: While some advocate progesterone for weight loss, evidence remains anecdotal; its role in lipid metabolism is still debated.
Dosage & Administration Routes
Dosage varies by indication and formulation:
●Oral (e.g., Prometrium): 100–400 mg/day, often causing drowsiness due to neurosteroid metabolites.
●Vaginal (Crinone gel): 90 mg daily for luteal support, minimizing hepatic first-pass effect.
●Intramuscular (IM): 50–200 mg/week, preferred in assisted reproduction but linked to injection-site reactions.
●Transdermal: Patches (e.g., Progesterone Bi-Estrogen Cream) offer steady absorption, ideal for HRT.
Cutting-Edge Delivery: Subcutaneous pellets provide sustained release over 3–6 months, gaining traction for HRT non-compliance.
Cyclical Dynamics & Half-Life
●Menstrual Cycle: Levels peak at 10–20 ng/mL during the luteal phase, inducing secretory endometrial changes. A drop triggers menstruation.
●Pregnancy: Rises exponentially, reaching 150–300 ng/mL in the third trimester, suppressing uterine contractions.
Half-Life:
○Oral: 5–20 hours (due to rapid liver metabolism).
○Vaginal/IM: 13–18 hours, offering prolonged efficacy.
New Finding: Genetic polymorphisms in CYP enzymes (e.g., CYP2C19) alter progesterone metabolism, necessitating personalized dosing in certain populations.
Preterm Birth Prevention (PTC)
Progesterone's role in preventing preterm labor (PTL) is well-established:
●Mechanism: Inhibits prostaglandins and oxytocin receptors, reducing uterine contractility.
●Regimens:
○Vaginal Suppositories: 200 mg/day from 16–20 weeks in high-risk women (e.g., short cervix).
○17α-Hydroxyprogesterone Caproate (17-OHPC): 250 mg IM weekly, though recent FDA withdrawal debates highlight efficacy controversies.
Innovative Research: Nanoparticle-based progesterone delivery is being tested to enhance cervical targeting and reduce dosing frequency.
Safety, Side Effects, & Interactions
●Common Side Effects: Dizziness, bloating, breast tenderness.
●Risks: Thrombosis (with synthetic progestins), mood swings.
●Drug Interactions: Rifampicin accelerates metabolism; ketoconazole inhibits it.
Cautionary Note: Bioidentical progesterone is often marketed as "safer," but lacks robust FDA oversight compared to FDA-approved formulations.
Future Directions & Research
●Cancer Implications: Dual role in breast tissue-protective in normal cells but potentially stimulative in BRCA-mutated cells.
●Gut-Brain Axis: Preliminary data suggest gut microbiota modulate enterohepatic recycling of progesterone, influencing bioavailability.
●Sustainable Synthesis: Plant-derived phyto-progesterones (e.g., from yams) are being engineered for eco-friendly production.
Clinical Data
|
Trade names |
Crinone, Endometrin,progesterone,4-pregnene-3,20-dione,P4 |
|
CAS |
57-83-0 |
|
Molar mass |
314.46 |
|
MF |
C21H30O2 |
|
Purity |
Above 98% |
|
Apprarance |
White crystalline powder |
Any needs, please contact us
Email: Jasonraws106@gmail.com
WhatsApp: +86-15572565525
Telegram: +86-19128233885

Conclusion
Progesterone's narrative transcends its label as a "pregnancy hormone." From neuroprotection to metabolic regulation, its applications are expanding, fueled by molecular insights and innovative delivery systems. However, personalized approaches are crucial to balance efficacy with safety, particularly in diverse populations. As research unravels its pleiotropic roles, progesterone stands poised to redefine therapeutic paradigms across medicine.
Hot Tags: progesterone cas:57-83-0, China progesterone cas:57-83-0 manufacturers, suppliers, factory, Anabolic Sterol Esters Clostebol Acetate, Boldenone Undecylenate wholesale price, Drostanolone Enanthate steroids, Letrozole Treating breast cancer, Trenbolone Enanthate, Vardenafil Treat men with erectile dysfunction
